Brief: Nicox: Zerviate Receives Approval To Carry Out Phase III Clinical Trial In China
22/09/2020 06:46
Sept 22 (Reuters) - Nicox SA NCOX.PA :
* NICOX’S ZERVIATE RECEIVES IND APPROVAL IN CHINA
* PHASE 3 TRIAL IS EXPECTED TO START IN Q4 2020
* PARTNER, OCUMENSION THERAPEUTICS, HAS RECEIVED APPROVAL
FROM
CHINA'S CENTER FOR DRUG EVALUATION OF NATIONAL MEDICAL PRODUCTS
ADMINISTRATION TO CARRY OUT PHASE 3 CLINICAL TRIALS ON ZERVIATE
(TM)
* TRIAL FOR TREATMENT OF OCULAR ITCHING ASSOCIATED WITH
ALLERGIC
CONJUNCTIVITIS
Source text for Eikon: ID:nGNX98Pdmk
Further company coverage: NCOX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))